Cryptosporidium parvum oocyst viability can be determined by vital dyes, in vitro excystation, and cell culture; however, neonatal mouse infectivity assays are the reference method. Unfortunately, there have been few efforts to standardize methods for infectivity assays thus casting a veil of uncertainty over the significance and comparability of results. In order to address this issue, two laboratories proficient in measuring oocyst infectivity conducted independent dose titration studies with neonatal CD-1 mice using standardized protocols and a well-characterized isolate of Cryptosporidium parvum. The resulting independent logistic dose-response models derived by regression analysis were compared with each other and with a published model. The comparisons showed these dose-response functions to be reproducible under standardized conditions. It is important to standardize mouse strain, age of mice at inoculation and necropsy, oocyst isolate, and age of oocysts. However, other factors, including methods used to detect infectivity and to count oocyst doses, appear less critical. Adopting a standardized assay for oocyst infectivity will provide both a basis for comparing data from various oocyst disinfection studies and a suitable platform for evaluating new or existing in vitro viability surrogates such as excystation, vital dyes or cell culture.
How to translate text using browser tools
1 May 2000
Inter-laboratory Comparison of the CD-1 Neonatal Mouse Logistic Dose-Response Model for Cryptosporidium parvum Oocysts
D.G. Korich,
M.M. Marshall,
H.V. SMITH,
J. O'GRADY,
Z. Bukhari,
C.R. Fricker,
J.P. Rosen,
J.L. Clancy
ACCESS THE FULL ARTICLE
It is not available for individual sale.
This article is only available to subscribers.
It is not available for individual sale.
It is not available for individual sale.
The Journal of Eukaryotic Microbiology
Vol. 47 • No. 3
May 2000
Vol. 47 • No. 3
May 2000
DAPI-PI
disinfection
excystation
in vitro assays
in vivo assays
infectivity
Standardization